Importantly, previously revealed ability of chaetocin to cross blood brain barrier51, as well as our illustration on potency of chaetocin and TRAIL combination in reducing tumor growth in vivo offers a potential therapeutic approach against GBM. The gene discussed is TNFSF10; the disease is glioblastoma.